StemCells, Inc. Completes Dosing in Second Trial of HuCNS-SC(R) Neural Stem Cells StemCells, Inc. announced that the fourth and final patient in its Phase I clinical trial in Pelizaeus-Merzbacher Disease (PMD) has been transplanted with the Company’s HuCNS-SC(R) cells (purified human neural stem cells). [StemCells, Inc. Press Release] Vote Now for Your Favorite 2011 Neuro Film Festival Video The video entries for the 2011 Neuro Film FestivalSM are in and the public can now begin voting on its “Fan Favorite” video through March 8, 2011. Neuro Film Festival is a contest hosted by the American Academy of Neurology Foundation to help raise awareness through video about brain disorders and the need to support research into preventions, treatments and cures. [American Academy of Neurology Press Release] Fipamezole Transition from Biovail Completed – Program Well Advanced Towards Phase III Santhera Pharmaceuticals announced that the transition of the fipamezole program back from Biovail was successfully completed. Fipamezole is being developed as a potential first treatment of Dyskinesia in Parkinson’s Disease. [Santhera Pharmaceuticals Press Release] Former Capital One Director and Business Leader Stanley I. Westreich Joins Neuralstem’s Board Neuralstem, Inc. announces the appointment of business leader Stanley I. Westreich to its Board of Directors. With his appointment the company’s board is now comprised of a majority of independent directors. [Neuralstem, Inc. Press Release] Three Researchers Awarded $100,000 Potamkin Prize from AAN The American Academy of Neurology (AAN) is awarding its 2011 Potamkin Prize to three researchers for their work in dementia. Dennis Dickson, MD, with the Mayo Clinic in Jacksonville, Florida, Eva Maria Mandelkow, MD, PhD, and Eckhard Mandelkow, PhD, both of the Max-Planck-Unit for Structural Molecular Biology in Hamburg, Germany, will receive the Award during the AAN’s 63rd Annual Meeting in Hawaii, April 9 – 16, 2011. [American Academy of Neurology Press Release] Society for Neuroscience Awarded $1.53 Million to Create Brainfacts.org The Society for Neuroscience (SfN) has been awarded $1.53 million in funding over six years to create and maintain BrainFacts.org, a unique nonprofit online source for authoritative public information about the progress and promise of brain research. [Society for Neuroscience Press Release] Elan and PPD Announce Global Business Relationship in Drug Development Elan, plc and PPD, Inc. announced they have formed a global business collaboration focused on the advancement, progression and execution of Elan’s development portfolio. [Elan, plc Press Release] |